End-of-day quote
Other stock markets
|
||
- PTS | - |
Business Summary
Sales per Business
SEK in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Vaccines
100.0
%
| 14 | 100.0 % | 6 | 100.0 % | -55.21% |
Sales per region
SEK in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Other Countries
88.6
%
| 8 | 67.2 % | 5 | 88.6 % | -45.21% |
Nordics
11.4
%
| 4 | 32.8 % | 1 | 11.4 % | -85.50% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Bent Frandsen
CEO | Chief Executive Officer | - | 15-12-31 |
Keith Alexander
DFI | Director of Finance/CFO | 48 | 20-09-30 |
Max M. Søgaard
CTO | Chief Tech/Sci/R&D Officer | - | 12-12-31 |
Chief Tech/Sci/R&D Officer | 70 | 23-01-15 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jakob Knudsen
BRD | Director/Board Member | 56 | 17-03-31 |
Karin Garre
BRD | Director/Board Member | 67 | 21-05-25 |
Martin Jensen
FOU | Founder | 64 | 09-12-31 |
Sara Sande
BRD | Director/Board Member | 49 | 21-05-25 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 111,377,409 | 51,404,958 ( 46.15 %) | 0 | 46.15 % |
Company contact information
Expres2ion Biotech Holding AB
SCION-DTU Science Park Agern Allé 1
2970, Hørsholm
+
http://www.expres2ionbio.comSector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+0.82% | 91.94B | |
-3.16% | 38.74B | |
+64.83% | 26.66B | |
-12.78% | 15.32B | |
-5.71% | 13.3B | |
-11.38% | 11.65B | |
+156.85% | 10.37B | |
-49.84% | 10.12B | |
+2.32% | 9.06B |
- Stock Market
- Equities
- EXPRS2 Stock
- Stock
- Company EXPN BIOT